Dr Lucy Dumas
Presentation Roadmap/ Summary
The older adult population is heterogeneous. This session will demonstrate that identifying those patients at higher risk of cancer treatment related toxicity and poorer survival outcomes, allows for improved patient-centred decision-making, reducing the risk of over or under-treatment. Geriatric assessment is a holistic, ideally multidisciplinary diagnostic process to identify care needs, plan care and improve outcomes of frail older people. Nutritional assessment is an essential component of a geriatric assessment and has been shown to be consistently associated with poorer treatment related and survival outcomes. Sarcopenia (the loss of muscle mass, quality and strength) is more common with increasing age and frailty and is associated with poorer cancer survival outcomes in a number of different malignancies. It is attractive both as a clinical marker and as a future direction for research given it is readily measurable using cross-sectional imaging and clinical techniques. Moreover, there is evidence that sarcopenia is reversible and thus developing our understanding of the inter-relationships between frailty, nutrition and saropenia is essential to develop approaches to address this increasingly relevant condition.
Learning Objectives
At the conclusion of the presentation, the participant will understand that:
Key Takeaways/ Fast Facts
Key references
Using this link will let you leave a website of Fresenius Kabi Deutschland GmbH (“Fresenius Kabi”) or to a different domain under the control of Fresenius Kabi. In the event that the linked site is not under the control of Fresenius Kabi but under the control of a third party or an affiliate in the Fresenius group of companies, Fresenius Kabi shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Fresenius Kabi of the site.
Do you want to continue?